Dr. Inderjit Mehmi, MD

Claim this profile

The Angeles Clinic and Research Institute

Studies Melanoma

Studies Skin Cancer

9 reported clinical trials

12 drugs studied

Area of expertise

1Melanoma

Inderjit Mehmi, MD has run 7 trials for Melanoma. Some of their research focus areas include:

Stage IV

Stage III

EGFR negative

2Skin Cancer

Inderjit Mehmi, MD has run 6 trials for Skin Cancer. Some of their research focus areas include:

Stage IV

Stage III

Affiliated Hospitals

The Angeles Clinic And Research Institute

The Angeles Clinic And Research Institute - West Los Angeles Office

Clinical Trials Inderjit Mehmi, MD is currently running

More about Inderjit Mehmi, MD

Clinical Trial Related3 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 3 Active Clinical Trials

Treatments Inderjit Mehmi, MD has experience with

Pembrolizumab
Nivolumab
TBX-3400
Ipilimumab
Nivolumab + Relatlimab Fixed-dose Combination (FDC)
Brentuximab Vedotin

Breakdown of trials Inderjit Mehmi, MD has run

Melanoma

Skin Cancer

Squamous Cell Carcinoma

Brentuximab Vedotin + Pembrolizumab for Advanced Cancers

Lung Cancer

Brentuximab Vedotin + Pembrolizumab for Advanced Cancers

Cutaneous Melanoma

Biomarker-Guided Immunotherapy Discontinuation for Melanoma

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).

What does Inderjit Mehmi, MD specialize in?

Inderjit Mehmi, MD focuses on Melanoma and Skin Cancer. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.

Is Inderjit Mehmi, MD currently recruiting for clinical trials?

Yes, Inderjit Mehmi, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.

Are there any treatments that Inderjit Mehmi, MD has studied deeply?

Yes, Inderjit Mehmi, MD has studied treatments such as Pembrolizumab, Nivolumab, TBX-3400.

What is the best way to schedule an appointment with Inderjit Mehmi, MD?

Apply for one of the trials that Inderjit Mehmi, MD is conducting.

What is the office address of Inderjit Mehmi, MD?

The office of Inderjit Mehmi, MD is located at: The Angeles Clinic and Research Institute, Los Angeles, California 90025 United States. This is the address for their practice at the The Angeles Clinic and Research Institute.

Is there any support for travel costs?

The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.

Top trials Inderjit Mehmi, MD is currently running

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.

1045 Sansome St, Suite 321, San Francisco, CA

hello@withpower.com (415) 900-4227

Directories

Locations

Psychology Related

Treatments

Cities

···

Dr. Inderjit Mehmi, MD

The Angeles Clinic and Research Institute

Area of expertise

Affiliated Hospitals

Clinical Trials Inderjit Mehmi, MD is currently running

More about Inderjit Mehmi, MD

Other Doctors you might be interested in

Frequently asked questions

Personalize Your Experience

Save Your Preferences

Understand How the Site Is Used

Dr. Inderjit Mehmi, MD

The Angeles Clinic and Research Institute

Area of expertise

Affiliated Hospitals

Clinical Trials Inderjit Mehmi, MD is currently running

Tumor-Treating Fields + Immunotherapy

for Uveal Melanoma

This trial is testing a new cancer treatment that uses electric fields to stop cancer cell growth. It targets patients with metastatic uveal melanoma, who often do not respond well to current treatments. The treatment works by boosting the immune system to help fight the cancer.

Sarilumab + Immunotherapy

for Melanoma

This trial tests a combination of drugs, including one usually for arthritis and three for cancer. It targets patients with advanced melanoma that can't be surgically removed. The drugs help the immune system attack the cancer by blocking proteins that help the cancer grow.

More about Inderjit Mehmi, MD

Other Doctors you might be interested in

Frequently asked questions